3R3-32374-01675
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 070 / NJ
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-10
Registered in v-safe
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-25
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-09
- 2021-10-08
-
2021-11-01
Dose 2 — Pfizer-BioNTech
-
2022-09-25
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-01
Survey response — days 1–6 daily, dose 3MedDRA: COVID-19 — Feeling: GoodFree text: Covid positive last weekMedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-01 | Pfizer-BioNTech | No |
| 3 | 2022-09-25 | Pfizer-BioNTech | Flu |
Free text
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Covid positive last week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release